Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W.
Kadmus Pharmaceuticals, Inc., Irvine, CA, United States
Search 32 grants from Kelvin Gee
Search grants from Kadmus Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens
Bath Salts &the Illicit Drug Market: Use, Violence &Health Consequences
Attentional Modulation of Brain Representations
Seleno Methionine Incorporation in Recombinant Proteins for Xray Crystallograph
Clinical Change in Phonological Categories
Recently added grants:
Information Dissemination Core
Targeting apoptotic caspases to enhance cancer radiotherapy
Animal Production Core
Pilot Project Core
Stress, social buffering, and oxytocin regulation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
3R41MH060527-01A1S1
Application #
6486311
Study Section
Special Emphasis Panel (ZRG1 (02))
Program Officer
Kelty, Miriam F
Project Start
2000-06-01
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2001
Total Cost
$7,023
Indirect Cost
Institution
Name
Kadmus Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Irvine
State
CA
Country
United States
Zip Code
92612
Related projects
NIH 2001
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$7,023
NIH 2000
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$120,208
Comments
Be the first to comment on this grant